
Cuorips Inc.
4894.TJPXHealthcareBiotechnology
Latest quote
¥5,260
+¥10.00 · +0.19%
4894.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteCuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Takayuki Kusanagi
- Listed since
- Jun 27, 2023
- Employees
- 51
Market position
Day range
Current ¥5,260
52-week range
Current ¥5,260
- Open
- ¥5,230
- Previous close
- ¥5,250
- Volume
- 15.5K
- 0.12× average
- Average volume
- 124.31K
- Average daily volume
- Market cap
- 43.43B JPY
- Beta
- 0.85
- Market reference 1
- 50-day average
- ¥4,503.4
- +16.80% above average
- 200-day average
- ¥6,205.38
- -15.23% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- -38.02×
- P/B (TTM)
- 9.78×
- P/S (TTM)
- 337.77×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 3.99%
- Operating margin
- -947.31%
- Net margin
- -886.40%
Financial health
- Debt / equity
- 0×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 212.33M JPY | 175.21M JPY | 23.1M JPY | 38.28M JPY | 13.91M JPY |
| Cost of goods sold | 166.43M JPY | 83.64M JPY | 83.57M JPY | 95.92M JPY | 96M JPY |
| Gross profit | 45.9M JPY | 91.56M JPY | −60.47M JPY | −57.64M JPY | −82.09M JPY |
| Research and development | — | 334.13M JPY | 209.77M JPY | 648.46M JPY | 112.81M JPY |
| Selling, general, and administrative | 1.13B JPY | 347.69M JPY | 318.24M JPY | 392.79M JPY | 178.37M JPY |
| Operating expenses | 1.13B JPY | 681.82M JPY | 528.02M JPY | 392.79M JPY | 291.11M JPY |
| Interest income | 13.39M JPY | 4.09M JPY | 45K JPY | 11K JPY | — |
| Depreciation and amortization | 84.45M JPY | 76.69M JPY | 70.1M JPY | 78.66M JPY | 92.74M JPY |
| Operating income | −1.08B JPY | −590.26M JPY | −588.49M JPY | −450.44M JPY | −373.2M JPY |
| Net income | −1.02B JPY | −644.34M JPY | −632.18M JPY | −452.08M JPY | −375.34M JPY |
Company facts updated Aug 25, 2026.
Earnings
- Latest EPS result
- -38.48
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
ETFs holding 4894.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 4894.Tresearch.disclaimer
